CIK 0001622229
- Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465308248
- Phone
- +1 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,689,493
- in 1 filing, $1.7M under 10b5-1 plans
Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-14 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +7,131 | $1.67 | $12K | 7,131 |
| 2019-04-01 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +4,369 | $2.72 | $12K | 4,369 |
| 2019-01-02 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +4,397 | $2.70 | $12K | 4,397 |
| 2018-10-01 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +1,910 | $6.22 | $12K | 1,910 |
| 2018-07-26 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +1,361 | $8.72 | $12K | 1,361 |
Page 1 of 1 · 5 trades